China’s Fosun Pharma unit strikes US$2.1 billion obesity drug deal with Pfizer
- Posted on December 10, 2025
- By South China Morning Post
- 7 Views
China’s Fosun Pharma unit strikes US$2.1 billion obesity drug deal with Pfizer
Yao Pharma’s deal with the US pharmaceutical giant underscores China’s growing role in global biotech licensing.
